Effect of ayurvedic treatment in diabetic nephropathy: a case study

National Journal Of Research in Ayurved Science

Article pdf download
Publication Certificate

Keywords

DIABETIC NEOHROPATHY, CHRONIC KIDNEY DISEASE, VAJERI BASTI, RENAL PROFIE, VRIKKA ROG.

How to Cite

vaidya, minal, & parab, swapnil. (2019). Effect of ayurvedic treatment in diabetic nephropathy: a case study. National Journal of Research in Ayurved Science, 7(02). Retrieved from http://ayurlog.com/index.php/ayurlog/article/view/311

Abstract

AIM & BACKGROUND: Diabetic nephropathy (DN), also known as diabetic kidney disease, is the chronic loss of kidney function occurring in those with diabetes mellitus. Protein loss in the urine due to damage to the glomeruli may become massive, and cause a low serum albumin with resulting generalized body swelling and result in the nephrotic syndrome. Likewise, the estimated glomerular filtration rate (eGFR) may progressively fall from a normal of over 90 ml/min/1.73m2 to less than 15, at which point the patient is said to have end-stage kidney (ESKD). It is usually slowly progressive over years.

CASE DESCRIPTION: A 70 year old female k/c/o DM for 10 years presenting with anasarca, puffiness of face, nausea, vomiting, weakness, hiccups, oliguria and itching all over body. Her renal and diabetic profile were deranged with huge proteinuria. Patient was on OHA (oral hypoglycaemic agent). According to ayurved she was diagnosed as case of prameha upadrav janya kapha pradhan vrikka rog.

 OUTCOME: After 11 days of vajeri basti and oral medication the patient showed significant relief in symptoms as well as reports.

CONCLUSION: Significant relief can be achieved in patients of diabetic nephropathy by applying classical ayurvedic principles. It’s a single case study and can lead down road for further research

KEYWORDS: DIABETIC NEOHROPATHY, CHRONIC KIDNEY DISEASE, VAJERI BASTI, RENAL PROFIE, VRIKKA ROG.

Article pdf download
Publication Certificate
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.